-
1
-
-
0030854715
-
Cellular energy utilization and molecular origin of standard metabolic rate in mammals
-
Rolfe DF, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 1997; 77: 731-58.
-
(1997)
Physiol Rev
, vol.77
, pp. 731-758
-
-
Rolfe, D.F.1
Brown, G.C.2
-
2
-
-
78149359713
-
Mitochondria in response to nutrients and nutrient-sensitive pathways
-
Baltzer C, Tiefenbock SK, Frei C. Mitochondria in response to nutrients and nutrient-sensitive pathways. Mitochondrion 2010; 10: 589-97.
-
(2010)
Mitochondrion
, vol.10
, pp. 589-597
-
-
Baltzer, C.1
Tiefenbock, S.K.2
Frei, C.3
-
3
-
-
4043086952
-
Mitochondria in health and disease: Perspectives on a new mitochondrial biology
-
Duchen MR. Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Aspects Med 2004; 25: 365-451.
-
(2004)
Mol Aspects Med
, vol.25
, pp. 365-451
-
-
Duchen, M.R.1
-
4
-
-
23844558266
-
A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine
-
Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005; 39: 359-407.
-
(2005)
Annu Rev Genet
, vol.39
, pp. 359-407
-
-
Wallace, D.C.1
-
5
-
-
4744340701
-
Mitochondriomics or what makes us breathe
-
Reichert AS, Neupert W. Mitochondriomics or what makes us breathe. Trends Genet 2004; 20: 555-62.
-
(2004)
Trends Genet
, vol.20
, pp. 555-562
-
-
Reichert, A.S.1
Neupert, W.2
-
7
-
-
79959354999
-
Mitochondria and the autophagy-inflammation-cell death axis in organismal aging
-
Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 2011; 333: 1109-12.
-
(2011)
Science
, vol.333
, pp. 1109-1112
-
-
Green, D.R.1
Galluzzi, L.2
Kroemer, G.3
-
8
-
-
80155135813
-
Mitochondrial mayhem: The mitochondrion as a modulator of iron metabolism and its role in disease
-
Huang ML, Lane DJ, Richardson DR. Mitochondrial mayhem: the mitochondrion as a modulator of iron metabolism and its role in disease. Antioxid Redox Signal 2011; 15: 3003-19.
-
(2011)
Antioxid Redox Signal
, vol.15
, pp. 3003-3019
-
-
Huang, M.L.1
Lane, D.J.2
Richardson, D.R.3
-
10
-
-
79957597757
-
Mitochondria in innate immune responses. Nature Reviews
-
West AP, Shadel GS, Ghosh S. Mitochondria in innate immune responses. Nature Reviews. Immunology 2011; 11: 389-402.
-
(2011)
Immunology
, vol.11
, pp. 389-402
-
-
West, A.P.1
Shadel, G.S.2
Ghosh, S.3
-
11
-
-
42049114034
-
Transcriptional paradigms in mammalian mitochondrial biogenesis and function
-
Scarpulla RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Revs 2008; 88: 611-38.
-
(2008)
Physiol Revs
, vol.88
, pp. 611-638
-
-
Scarpulla, R.C.1
-
12
-
-
67651159365
-
Transcriptional control of mitochondrial biogenesis and function
-
Hock MB, Kralli A. Transcriptional control of mitochondrial biogenesis and function. Annu Rev Physiol 2009; 71: 177-203.
-
(2009)
Annu Rev Physiol
, vol.71
, pp. 177-203
-
-
Hock, M.B.1
Kralli, A.2
-
14
-
-
84867431174
-
Rethinking the Regulation of Cellular Metabolism
-
Thompson CB. Rethinking the Regulation of Cellular Metabolism. Cold spring harb symp quant biol 2011; 76:23-9.
-
(2011)
Cold spring harb symp quant biol
, vol.76
, pp. 23-29
-
-
Thompson, C.B.1
-
16
-
-
80052073973
-
The cell cycle, including the mitotic cycle and organelle division cycles, as revealed by cytological observations
-
Imoto Y, Yoshida Y, Yagisawa F, Kuroiwa H, Kuroiwa T. The cell cycle, including the mitotic cycle and organelle division cycles, as revealed by cytological observations. J Electron Microsc 2011; 60 Suppl 1: S117-36.
-
(2011)
J Electron Microsc
, vol.60
, Issue.SUPPL. 1
-
-
Imoto, Y.1
Yoshida, Y.2
Yagisawa, F.3
Kuroiwa, H.4
Kuroiwa, T.5
-
17
-
-
79959719913
-
Established and novel Cdk/cyclin complexes regulating the cell cycle and development
-
Gopinathan L, Ratnacaram CK, Kaldis P. Established and novel Cdk/cyclin complexes regulating the cell cycle and development. Results Probl Cell Differ 2011; 53: 365-89.
-
(2011)
Results Probl Cell Differ
, vol.53
, pp. 365-389
-
-
Gopinathan, L.1
Ratnacaram, C.K.2
Kaldis, P.3
-
18
-
-
77957122174
-
The engine driving the ship: Metabolic steering of cell proliferation and death
-
Buchakjian MR, Kornbluth S. The engine driving the ship: metabolic steering of cell proliferation and death. Nat Rev Mol Cell Biol 2010; 11: 715-27.
-
(2010)
Nat Rev Mol Cell Biol
, vol.11
, pp. 715-727
-
-
Buchakjian, M.R.1
Kornbluth, S.2
-
19
-
-
33745858709
-
Cyclin D1 determines mitochondrial function in vivo
-
Sakamaki T, Casimiro MC, Ju X, et al. Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol 2006; 26: 5449-69.
-
(2006)
Mol Cell Biol
, vol.26
, pp. 5449-5469
-
-
Sakamaki, T.1
Casimiro, M.C.2
Ju, X.3
-
20
-
-
77955470822
-
Metabolism and proliferation share common regulatory pathways in cancer cells
-
Fritz V, Fajas L. Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene 2010; 29: 4369-77.
-
(2010)
Oncogene
, vol.29
, pp. 4369-4377
-
-
Fritz, V.1
Fajas, L.2
-
21
-
-
0032735328
-
Fructose-2,6-bisphosphate and control of carbohydrate metabolism in eukaryotes
-
Okar DA, Lange AJ. Fructose-2,6-bisphosphate and control of carbohydrate metabolism in eukaryotes. Biofactors 1999; 10: 1-14.
-
(1999)
Biofactors
, vol.10
, pp. 1-14
-
-
Okar, D.A.1
Lange, A.J.2
-
22
-
-
69949122828
-
Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases
-
Yalcin A, Clem BF, Simmons A, et al. Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J Biol Chem 2009; 284: 24223-32.
-
(2009)
J Biol Chem
, vol.284
, pp. 24223-24232
-
-
Yalcin, A.1
Clem, B.F.2
Simmons, A.3
-
23
-
-
28444496362
-
Mitochondrial regulation of cell cycle progression during development as revealed by the tenured mutation in Drosophila
-
Mandal S, Guptan P, Owusu-Ansah E, Banerjee U. Mitochondrial regulation of cell cycle progression during development as revealed by the tenured mutation in Drosophila. Dev Cell 2005; 9: 843-54.
-
(2005)
Dev Cell
, vol.9
, pp. 843-854
-
-
Mandal, S.1
Guptan, P.2
Owusu-Ansah, E.3
Banerjee, U.4
-
24
-
-
0026016342
-
Histone acetylation and histone synthesis in mouse fibroblasts during quiescence and restimulation into S-phase
-
Knosp O, Talasz H, Puschendorf B. Histone acetylation and histone synthesis in mouse fibroblasts during quiescence and restimulation into S-phase. Mol Cell Biochem 1991; 101: 51-8.
-
(1991)
Mol Cell Biochem
, vol.101
, pp. 51-58
-
-
Knosp, O.1
Talasz, H.2
Puschendorf, B.3
-
25
-
-
66249105703
-
ATP-citrate lyase links cellular metabolism to histone acetylation
-
Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009; 324: 1076-80.
-
(2009)
Science
, vol.324
, pp. 1076-1080
-
-
Wellen, K.E.1
Hatzivassiliou, G.2
Sachdeva, U.M.3
Bui, T.V.4
Cross, J.R.5
Thompson, C.B.6
-
26
-
-
52649107626
-
Cancer cell metabolism: Warburg and beyond
-
Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell 2008; 134: 703-7.
-
(2008)
Cell
, vol.134
, pp. 703-707
-
-
Hsu, P.P.1
Sabatini, D.M.2
-
27
-
-
37449024702
-
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
-
DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008; 7: 11-20.
-
(2008)
Cell Metab
, vol.7
, pp. 11-20
-
-
DeBerardinis, R.J.1
Lum, J.J.2
Hatzivassiliou, G.3
Thompson, C.B.4
-
29
-
-
84858796367
-
A two-way street: Reciprocal regulation of metabolism and signalling
-
Wellen KE, Thompson CB. A two-way street: reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol 2012; 13: 270-6.
-
(2012)
Nat Rev Mol Cell Biol
, vol.13
, pp. 270-276
-
-
Wellen, K.E.1
Thompson, C.B.2
-
30
-
-
66949165559
-
Autophagy in disease: A double-edged sword with therapeutic potential
-
Martinet W, Agostinis P, Vanhoecke B, Dewaele M, De Meyer GR. Autophagy in disease: a double-edged sword with therapeutic potential. Clin Sci 2009; 116: 697-712.
-
(2009)
Clin Sci
, vol.116
, pp. 697-712
-
-
Martinet, W.1
Agostinis, P.2
Vanhoecke, B.3
Dewaele, M.4
De Meyer, G.R.5
-
31
-
-
84858604270
-
Metabolic reprogramming: A cancer hallmark even warburg did not anticipate
-
Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012; 21: 297-308.
-
(2012)
Cancer Cell
, vol.21
, pp. 297-308
-
-
Ward, P.S.1
Thompson, C.B.2
-
32
-
-
0021792065
-
The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells
-
Newsholme EA, Crabtree B, Ardawi MS. The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells. Biosci Rep 1985; 5: 393-400.
-
(1985)
Biosci Rep
, vol.5
, pp. 393-400
-
-
Newsholme, E.A.1
Crabtree, B.2
Ardawi, M.S.3
-
33
-
-
33750619348
-
Glucose metabolism and cancer
-
Shaw RJ. Glucose metabolism and cancer. Curr Opin Cell Biol 2006; 18: 598-608.
-
(2006)
Curr Opin Cell Biol
, vol.18
, pp. 598-608
-
-
Shaw, R.J.1
-
34
-
-
44449147036
-
Tumor cell metabolism: Cancer's Achilles' heel
-
Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008; 13: 472-82.
-
(2008)
Cancer Cell
, vol.13
, pp. 472-482
-
-
Kroemer, G.1
Pouyssegur, J.2
-
35
-
-
69949124867
-
Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells
-
Feron O. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiotherap Oncol 2009; 92: 329-33.
-
(2009)
Radiotherap Oncol
, vol.92
, pp. 329-333
-
-
Feron, O.1
-
37
-
-
66249108601
-
Understanding the Warburg effect: The metabolic requirements of cell proliferation
-
Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029-33.
-
(2009)
Science
, vol.324
, pp. 1029-1033
-
-
Vander Heiden, M.G.1
Cantley, L.C.2
Thompson, C.B.3
-
38
-
-
77649187905
-
The Warburg effect and mitochondrial stability in cancer cells
-
Gogvadze V, Zhivotovsky B, Orrenius S. The Warburg effect and mitochondrial stability in cancer cells. Mol Aspects Med 2010; 31: 60-74.
-
(2010)
Mol Aspects Med
, vol.31
, pp. 60-74
-
-
Gogvadze, V.1
Zhivotovsky, B.2
Orrenius, S.3
-
39
-
-
79551646672
-
Survival of the fittest: Metabolic adaptations in cancer
-
Berardi MJ, Fantin VR. Survival of the fittest: metabolic adaptations in cancer. Curr Opin Genet Dev 2011; 21: 59-66.
-
(2011)
Curr Opin Genet Dev
, vol.21
, pp. 59-66
-
-
Berardi, M.J.1
Fantin, V.R.2
-
41
-
-
79953689833
-
Bioactive food components, cancer cell growth limitation and reversal of glycolytic metabolism
-
Keijer J, Bekkenkamp-Grovenstein M, Venema D, Dommels YE. Bioactive food components, cancer cell growth limitation and reversal of glycolytic metabolism. Biochim Biophys Acta 2011; 1807: 697-706.
-
(2011)
Biochim Biophys Acta
, vol.1807
, pp. 697-706
-
-
Keijer, J.1
Bekkenkamp-Grovenstein, M.2
Venema, D.3
Dommels, Y.E.4
-
42
-
-
84866601479
-
Regulation of Metabolism by Hypoxia-Inducible Factor 1
-
Semenza GL. Regulation of Metabolism by Hypoxia-Inducible Factor 1. Cold Spring Harb Symp Quant biol 2011; 76: 347-53.
-
(2011)
Cold Spring Harb Symp Quant biol
, vol.76
, pp. 347-353
-
-
Semenza, G.L.1
-
43
-
-
84858414020
-
Cellular metabolism and disease: What do metabolic outliers teach us?
-
DeBerardinis RJ, Thompson CB. Cellular metabolism and disease: what do metabolic outliers teach us? Cell 2012; 148: 1132-44.
-
(2012)
Cell
, vol.148
, pp. 1132-1144
-
-
DeBerardinis, R.J.1
Thompson, C.B.2
-
44
-
-
78649711427
-
The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes
-
Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010; 330: 1340-4.
-
(2010)
Science
, vol.330
, pp. 1340-1344
-
-
Levine, A.J.1
Puzio-Kuter, A.M.2
-
45
-
-
0036598992
-
Targeting death and decoy receptors of the tumornecrosis factor superfamily
-
Ashkenazi A. Targeting death and decoy receptors of the tumornecrosis factor superfamily. Nat Rev Cancer 2002; 2: 420-30.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 420-430
-
-
Ashkenazi, A.1
-
46
-
-
79551663808
-
The molecular machinery regulating apoptosis signal transduction and its implication in human physiology and pathophysiologies
-
Hellwig CT, Passante E, Rehm M. The molecular machinery regulating apoptosis signal transduction and its implication in human physiology and pathophysiologies. Curr Mol Med 2011; 11: 31-47.
-
(2011)
Curr Mol Med
, vol.11
, pp. 31-47
-
-
Hellwig, C.T.1
Passante, E.2
Rehm, M.3
-
47
-
-
84860389354
-
Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases
-
Strasser A, Cory S, Adams JM. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J 2011; 30: 3667-83.
-
(2011)
EMBO J
, vol.30
, pp. 3667-3683
-
-
Strasser, A.1
Cory, S.2
Adams, J.M.3
-
49
-
-
77956095537
-
Mitochondria and cell death: Outer membrane permeabilization and beyond
-
Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010; 11: 621-32.
-
(2010)
Nat Rev Mol Cell Biol
, vol.11
, pp. 621-632
-
-
Tait, S.W.1
Green, D.R.2
-
50
-
-
79953719964
-
Role of Bcl-2 family proteins and caspases in the regulation of apoptosis
-
Ola MS, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 2011; 351: 41-58.
-
(2011)
Mol Cell Biochem
, vol.351
, pp. 41-58
-
-
Ola, M.S.1
Nawaz, M.2
Ahsan, H.3
-
52
-
-
84255210700
-
Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012
-
Galluzzi L, Vitale I, Abrams JM, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107-20.
-
(2012)
Cell Death Differ
, vol.19
, pp. 107-120
-
-
Galluzzi, L.1
Vitale, I.2
Abrams, J.M.3
-
53
-
-
84859813980
-
Destabilization of the outer and inner mitochondrial membranes by core and linker histones
-
Cascone A, Bruelle C, Lindholm D, Bernardi P, Eriksson O. Destabilization of the outer and inner mitochondrial membranes by core and linker histones. Plos One 2012; 7: e35357.
-
(2012)
Plos One
, vol.7
-
-
Cascone, A.1
Bruelle, C.2
Lindholm, D.3
Bernardi, P.4
Eriksson, O.5
-
54
-
-
34247540380
-
The permeability transition pore in cell death
-
Grimm S, Brdiczka D. The permeability transition pore in cell death. Apoptosis 2007; 12: 841-55.
-
(2007)
Apoptosis
, vol.12
, pp. 841-855
-
-
Grimm, S.1
Brdiczka, D.2
-
55
-
-
79952007628
-
Adenine nucleotide translocase family: Four isoforms for apoptosis modulation in cancer
-
Brenner C, Subramaniam K, Pertuiset C, Pervaiz S. Adenine nucleotide translocase family: four isoforms for apoptosis modulation in cancer. Oncogene 2011; 30: 883-95.
-
(2011)
Oncogene
, vol.30
, pp. 883-895
-
-
Brenner, C.1
Subramaniam, K.2
Pertuiset, C.3
Pervaiz, S.4
-
56
-
-
33746924468
-
Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria
-
Mathupala SP, Ko YH, Pedersen PL. Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 2006; 25: 4777-86.
-
(2006)
Oncogene
, vol.25
, pp. 4777-4786
-
-
Mathupala, S.P.1
Ko, Y.H.2
Pedersen, P.L.3
-
57
-
-
84857873334
-
Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis
-
Chipuk JE, McStay GP, Bharti A, Kuwana T, Clarke CJ, Siskind LJ, Obeid LM, Green DR. Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 2012; 148: 988-1000.
-
(2012)
Cell
, vol.148
, pp. 988-1000
-
-
Chipuk, J.E.1
McStay, G.P.2
Bharti, A.3
Kuwana, T.4
Clarke, C.J.5
Siskind, L.J.6
Obeid, L.M.7
Green, D.R.8
-
58
-
-
59449098471
-
Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling
-
Dorn GW, 2nd. Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res 2009; 81: 465-73.
-
(2009)
Cardiovasc Res
, vol.81
, pp. 465-473
-
-
Dorn II, G.W.1
-
59
-
-
84863552418
-
A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans
-
Bricker DK, Taylor EB, Schell JC, et al. A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science 2012; 337: 96-100.
-
(2012)
Science
, vol.337
, pp. 96-100
-
-
Bricker, D.K.1
Taylor, E.B.2
Schell, J.C.3
-
60
-
-
78650869592
-
Mitochondrial ROS generation and its regulation: Mechanisms involved in H(2)O(2) signaling
-
Rigoulet M, Yoboue ED, Devin A. Mitochondrial ROS generation and its regulation: mechanisms involved in H(2)O(2) signaling. Antioxid Redox Signal 2011; 14: 459-68.
-
(2011)
Antioxid Redox Signal
, vol.14
, pp. 459-468
-
-
Rigoulet, M.1
Yoboue, E.D.2
Devin, A.3
-
61
-
-
77951953060
-
Mammalian mitochondrial complex I: Biogenesis, regulation, and reactive oxygen species generation
-
Koopman WJ, Nijtmans LG, Dieteren CE, et al. Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. Antioxid Redox Signal 2010; 12: 1431-70.
-
(2010)
Antioxid Redox Signal
, vol.12
, pp. 1431-1470
-
-
Koopman, W.J.1
Nijtmans, L.G.2
Dieteren, C.E.3
-
62
-
-
67650071137
-
Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach?
-
Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat rev drug discov 2009; 8: 579-91.
-
(2009)
Nat rev drug discov
, vol.8
, pp. 579-591
-
-
Trachootham, D.1
Alexandre, J.2
Huang, P.3
-
63
-
-
82355193798
-
Redox equivalents and mitochondrial bioenergetics
-
Roede JR, Go YM, Jones DP. Redox equivalents and mitochondrial bioenergetics. Methods Mol Biol 2012; 810: 249-80.
-
(2012)
Methods Mol Biol
, vol.810
, pp. 249-280
-
-
Roede, J.R.1
Go, Y.M.2
Jones, D.P.3
-
65
-
-
1542376929
-
Glutathione metabolism and its implications for health
-
Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004; 134: 489-92.
-
(2004)
J Nutr
, vol.134
, pp. 489-492
-
-
Wu, G.1
Fang, Y.Z.2
Yang, S.3
Lupton, J.R.4
Turner, N.D.5
-
66
-
-
0345328791
-
Mitochondrial impairment is accompanied by impaired oxidative DNA repair in the nucleus
-
Delsite RL, Rasmussen LJ, Rasmussen AK, Kalen A, Goswami PC, Singh KK. Mitochondrial impairment is accompanied by impaired oxidative DNA repair in the nucleus. Mutagenesis 2003; 18: 497-503.
-
(2003)
Mutagenesis
, vol.18
, pp. 497-503
-
-
Delsite, R.L.1
Rasmussen, L.J.2
Rasmussen, A.K.3
Kalen, A.4
Goswami, P.C.5
Singh, K.K.6
-
67
-
-
84859897794
-
Regulation of reactive oxygen species generation in cell signaling
-
Bae YS, Oh H, Rhee SG, Yoo YD. Regulation of reactive oxygen species generation in cell signaling. Mol Cells 2011; 32: 491-509.
-
(2011)
Mol Cells
, vol.32
, pp. 491-509
-
-
Bae, Y.S.1
Oh, H.2
Rhee, S.G.3
Yoo, Y.D.4
-
69
-
-
84864968186
-
Contribution of mitochondrial network dynamics to intracellular ROS signaling
-
Park J, Choi C. Contribution of mitochondrial network dynamics to intracellular ROS signaling. Commun Integr Biol 2012; 5: 81-3.
-
(2012)
Commun Integr Biol
, vol.5
, pp. 81-83
-
-
Park, J.1
Choi, C.2
-
70
-
-
79961149531
-
Mitochondrial network determines intracellular ROS dynamics and sensitivity to oxidative stress through switching inter-mitochondrial messengers
-
Park J, Lee J, Choi C. Mitochondrial network determines intracellular ROS dynamics and sensitivity to oxidative stress through switching inter-mitochondrial messengers. Plos One 2011; 6: e23211.
-
(2011)
Plos One
, vol.6
-
-
Park, J.1
Lee, J.2
Choi, C.3
-
71
-
-
77951238575
-
Mitochondrial regulation of oxygen sensing
-
Chandel NS. Mitochondrial regulation of oxygen sensing. Adv Exp Med Biol 2010; 661: 339-54.
-
(2010)
Adv Exp Med Biol
, vol.661
, pp. 339-354
-
-
Chandel, N.S.1
-
72
-
-
0000459772
-
Ueber den Stoffwechsel der Tumoren
-
Warburg O, Posener K, E. N. Ueber den Stoffwechsel der Tumoren. Biochem Z 1924; 152: 319-344.
-
(1924)
Biochem Z
, vol.152
, pp. 319-344
-
-
Warburg, O.1
Posener, K.E.N.2
-
74
-
-
82755195292
-
Tumor cell metabolism: An integral view
-
Romero-Garcia S, Lopez-Gonzalez JS, Baez-Viveros JL, Aguilar-Cazares D, Prado-Garcia H. Tumor cell metabolism: an integral view. Cancer Biol Ther 2011; 12: 939-48.
-
(2011)
Cancer Biol Ther
, vol.12
, pp. 939-948
-
-
Romero-Garcia, S.1
Lopez-Gonzalez, J.S.2
Baez-Viveros, J.L.3
Aguilar-Cazares, D.4
Prado-Garcia, H.5
-
75
-
-
77955281020
-
Glutamine addiction: A new therapeutic target in cancer
-
Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 2010; 35: 427-33.
-
(2010)
Trends Biochem Sci
, vol.35
, pp. 427-433
-
-
Wise, D.R.1
Thompson, C.B.2
-
76
-
-
33244464562
-
Critical nodes in signalling pathways: Insights into insulin action
-
Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006; 7: 85-96.
-
(2006)
Nat Rev Mol Cell Biol
, vol.7
, pp. 85-96
-
-
Taniguchi, C.M.1
Emanuelli, B.2
Kahn, C.R.3
-
78
-
-
77957241580
-
The proliferating role of insulin and insulin-like growth factors in cancer
-
Gallagher EJ, LeRoith D. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab 2010; 21: 610-8.
-
(2010)
Trends Endocrinol Metab
, vol.21
, pp. 610-618
-
-
Gallagher, E.J.1
LeRoith, D.2
-
79
-
-
71549172179
-
PI-3-K and AKT: Onto the mitochondria
-
Stiles BL. PI-3-K and AKT: Onto the mitochondria. Adv Drug Deliv Revs 2009; 61: 1276-82.
-
(2009)
Adv Drug Deliv Revs
, vol.61
, pp. 1276-1282
-
-
Stiles, B.L.1
-
80
-
-
67749122122
-
Targeting PI3K signalling in cancer: Opportunities, challenges and limitations
-
Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 2009; 9: 550-62.
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 550-562
-
-
Engelman, J.A.1
-
81
-
-
11244297916
-
Dysregulation of the TSCmTOR pathway in human disease
-
Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSCmTOR pathway in human disease. Nat Genet 2005; 37: 19-24.
-
(2005)
Nat Genet
, vol.37
, pp. 19-24
-
-
Inoki, K.1
Corradetti, M.N.2
Guan, K.L.3
-
82
-
-
27744588780
-
Tuberous sclerosis: A GAP at the crossroads of multiple signaling pathways
-
Kwiatkowski DJ, Manning BD. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 2005; 14: R251-8.
-
(2005)
Hum Mol Genet
, vol.14
-
-
Kwiatkowski, D.J.1
Manning, B.D.2
-
83
-
-
78650510609
-
mTOR: From growth signal integration to cancer, diabetes and ageing
-
Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nature Rev Mol Cell Biol 2011; 12: 21-35.
-
(2011)
Nature Rev Mol Cell Biol
, vol.12
, pp. 21-35
-
-
Zoncu, R.1
Efeyan, A.2
Sabatini, D.M.3
-
84
-
-
77955747346
-
With TOR, less is more: A key role for the conserved nutrient-sensing TOR pathway in aging
-
Kapahi P, Chen D, Rogers AN, et al. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab 2010; 11: 453-65.
-
(2010)
Cell Metab
, vol.11
, pp. 453-465
-
-
Kapahi, P.1
Chen, D.2
Rogers, A.N.3
-
85
-
-
78649348967
-
Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress
-
Sengupta S, Peterson TR, Sabatini DM. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Molec Cell 2010; 40: 310-22.
-
(2010)
Molec Cell
, vol.40
, pp. 310-322
-
-
Sengupta, S.1
Peterson, T.R.2
Sabatini, D.M.3
-
87
-
-
77952007543
-
Mammalian target of rapamycin (mTOR): Conducting the cellular signaling symphony
-
Foster KG, Fingar DC. Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J Biol Chem 2010; 285: 14071-7.
-
(2010)
J Biol Chem
, vol.285
, pp. 14071-14077
-
-
Foster, K.G.1
Fingar, D.C.2
-
88
-
-
84055178474
-
Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
-
Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J 2012; 441: 1-21.
-
(2012)
Biochem J
, vol.441
, pp. 1-21
-
-
Magnuson, B.1
Ekim, B.2
Fingar, D.C.3
-
89
-
-
70349438679
-
4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila
-
Zid BM, Rogers AN, Katewa SD, Vargas MA, Kolipinski MC, Lu TA, Benzer S, Kapahi P. 4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila. Cell 2009; 139: 149-60.
-
(2009)
Cell
, vol.139
, pp. 149-160
-
-
Zid, B.M.1
Rogers, A.N.2
Katewa, S.D.3
Vargas, M.A.4
Kolipinski, M.C.5
Lu, T.A.6
Benzer, S.7
Kapahi, P.8
-
90
-
-
57049186623
-
How to live long and prosper: Autophagy, mitochondria, and aging
-
Yen WL, Klionsky DJ. How to live long and prosper: autophagy, mitochondria, and aging. Physiology 2008; 23: 248-62.
-
(2008)
Physiology
, vol.23
, pp. 248-262
-
-
Yen, W.L.1
Klionsky, D.J.2
-
91
-
-
77950228925
-
Autophagy in health and disease. 1. Regulation and significance of autophagy: An overview
-
Mehrpour M, Esclatine A, Beau I, Codogno P. Autophagy in health and disease. 1. Regulation and significance of autophagy: an overview. Am J Physiol Cell Physiol 2010; 298: C776-85.
-
(2010)
Am J Physiol Cell Physiol
, vol.298
-
-
Mehrpour, M.1
Esclatine, A.2
Beau, I.3
Codogno, P.4
-
92
-
-
79957883170
-
The multiple roles of autophagy in cancer
-
Rosenfeldt MT, Ryan KM. The multiple roles of autophagy in cancer. Carcinogenesis 2011; 32: 955-63.
-
(2011)
Carcinogenesis
, vol.32
, pp. 955-963
-
-
Rosenfeldt, M.T.1
Ryan, K.M.2
-
93
-
-
79959415069
-
Biogenesis and cargo selectivity of autophagosomes
-
Weidberg H, Shvets E, Elazar Z. Biogenesis and cargo selectivity of autophagosomes. Annu Rev Biochem 2011; 80: 125-56.
-
(2011)
Annu Rev Biochem
, vol.80
, pp. 125-156
-
-
Weidberg, H.1
Shvets, E.2
Elazar, Z.3
-
94
-
-
78650467974
-
Mechanisms of mitophagy. Nature reviews
-
Youle RJ, Narendra DP. Mechanisms of mitophagy. Nature reviews. Mol Cell Biol 2011; 12: 9-14.
-
(2011)
Mol Cell Biol
, vol.12
, pp. 9-14
-
-
Youle, R.J.1
Narendra, D.P.2
-
95
-
-
80052426012
-
Metabolic profiling of hypoxic cells revealed a catabolic signature required for cell survival
-
Frezza C, Zheng L, Tennant DA, et al. Metabolic profiling of hypoxic cells revealed a catabolic signature required for cell survival. Plos One 2011; 6: e24411.
-
(2011)
Plos One
, vol.6
-
-
Frezza, C.1
Zheng, L.2
Tennant, D.A.3
-
96
-
-
79960014848
-
ULK1 inhibits mTORC1 signaling, promotes multisite Raptor phosphorylation and hinders substrate binding
-
Dunlop EA, Hunt DK, Acosta-Jaquez HA, Fingar DC, Tee AR. ULK1 inhibits mTORC1 signaling, promotes multisite Raptor phosphorylation and hinders substrate binding. Autophagy 2011; 7: 737-47.
-
(2011)
Autophagy
, vol.7
, pp. 737-747
-
-
Dunlop, E.A.1
Hunt, D.K.2
Acosta-Jaquez, H.A.3
Fingar, D.C.4
Tee, A.R.5
-
97
-
-
15044358594
-
New roles for the LKB1-->AMPK pathway
-
Hardie DG. New roles for the LKB1-->AMPK pathway. Curr opin cell biol 2005; 17: 167-73.
-
(2005)
Curr opin cell biol
, vol.17
, pp. 167-173
-
-
Hardie, D.G.1
-
98
-
-
42949139481
-
AMPK phosphorylation of raptor mediates a metabolic checkpoint
-
Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008; 30: 214-26.
-
(2008)
Mol Cell
, vol.30
, pp. 214-226
-
-
Gwinn, D.M.1
Shackelford, D.B.2
Egan, D.F.3
-
99
-
-
84857687439
-
AMPK functions as an adenylate charge-regulated protein kinase
-
Oakhill JS, Scott JW, Kemp BE. AMPK functions as an adenylate charge-regulated protein kinase. Trends Endocrinol Metab 2012 23: 125-32.
-
(2012)
Trends Endocrinol Metab
, vol.23
, pp. 125-132
-
-
Oakhill, J.S.1
Scott, J.W.2
Kemp, B.E.3
-
100
-
-
23044437445
-
Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells
-
Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M, Carling D. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2005; 2: 21-33.
-
(2005)
Cell Metab
, vol.2
, pp. 21-33
-
-
Woods, A.1
Dickerson, K.2
Heath, R.3
Hong, S.P.4
Momcilovic, M.5
Johnstone, S.R.6
Carlson, M.7
Carling, D.8
-
101
-
-
23044432463
-
Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase
-
Hawley SA, Pan DA, Mustard KJet al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell metab 2005; 2: 9-19.
-
(2005)
Cell metab
, vol.2
, pp. 9-19
-
-
Hawley, S.A.1
Pan, D.A.2
Mustard, K.J.3
-
102
-
-
33847072201
-
AMP-activated protein kinase as a drug target
-
Hardie DG. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol 2007; 47: 185-210.
-
(2007)
Annu Rev Pharmacol Toxicol
, vol.47
, pp. 185-210
-
-
Hardie, D.G.1
-
103
-
-
67650914230
-
AMPK in Health and Disease
-
Steinberg GR, Kemp BE. AMPK in Health and Disease. Physiol rev 2009; 89: 1025-78.
-
(2009)
Physiol rev
, vol.89
, pp. 1025-1078
-
-
Steinberg, G.R.1
Kemp, B.E.2
-
104
-
-
77949462458
-
AMPK as a metabolic tumor suppressor: Control of metabolism and cell growth
-
Luo Z, Zang M, Guo W. AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol 2010; 6: 457-70.
-
(2010)
Future Oncol
, vol.6
, pp. 457-470
-
-
Luo, Z.1
Zang, M.2
Guo, W.3
-
105
-
-
84858782079
-
AMPK: A nutrient and energy sensor that maintains energy homeostasis
-
Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012; 13: 251-62.
-
(2012)
Nat Rev Mol Cell Biol
, vol.13
, pp. 251-262
-
-
Hardie, D.G.1
Ross, F.A.2
Hawley, S.A.3
-
106
-
-
80052511813
-
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
-
Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 2011; 13: 1016-23.
-
(2011)
Nat Cell Biol
, vol.13
, pp. 1016-1023
-
-
Mihaylova, M.M.1
Shaw, R.J.2
-
107
-
-
79959338922
-
AMPK is a direct adenylate charge-regulated protein kinase
-
Oakhill JS, Steel R, Chen ZP, et al. AMPK is a direct adenylate charge-regulated protein kinase. Science 2011; 332: 1433-5.
-
(2011)
Science
, vol.332
, pp. 1433-1435
-
-
Oakhill, J.S.1
Steel, R.2
Chen, Z.P.3
-
108
-
-
0036645286
-
Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung
-
Sanchez-Cespedes M, Parrella P, Esteller M, et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res 2002; 62: 3659-62.
-
(2002)
Cancer Res
, vol.62
, pp. 3659-3662
-
-
Sanchez-Cespedes, M.1
Parrella, P.2
Esteller, M.3
-
109
-
-
63849193776
-
AMPK-dependent hormonal regulation of whole-body energy metabolism
-
Dzamko NL, Steinberg GR. AMPK-dependent hormonal regulation of whole-body energy metabolism. Acta Physiol 2009; 196: 115-27.
-
(2009)
Acta Physiol
, vol.196
, pp. 115-127
-
-
Dzamko, N.L.1
Steinberg, G.R.2
-
110
-
-
79251587803
-
Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy
-
Egan DF, Shackelford DB, Mihaylova MM, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011; 331: 456-61.
-
(2011)
Science
, vol.331
, pp. 456-461
-
-
Egan, D.F.1
Shackelford, D.B.2
Mihaylova, M.M.3
-
113
-
-
33745918951
-
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
-
Bensaad K, Tsuruta A, Selak MA, et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006; 126: 107-20.
-
(2006)
Cell
, vol.126
, pp. 107-120
-
-
Bensaad, K.1
Tsuruta, A.2
Selak, M.A.3
-
114
-
-
33750622643
-
Redox regulation of the hypoxia-inducible factor
-
Pouyssegur J, Mechta-Grigoriou F. Redox regulation of the hypoxia-inducible factor. Biol Chem 2006; 387: 1337-46.
-
(2006)
Biol Chem
, vol.387
, pp. 1337-1346
-
-
Pouyssegur, J.1
Mechta-Grigoriou, F.2
-
115
-
-
60549083256
-
Regulation of cancer cell metabolism by hypoxiainducible factor 1
-
Semenza GL. Regulation of cancer cell metabolism by hypoxiainducible factor 1. Sem Cancer Biol 2009; 19: 12-6.
-
(2009)
Sem Cancer Biol
, vol.19
, pp. 12-16
-
-
Semenza, G.L.1
-
116
-
-
84859445000
-
Hypoxia-inducible factors: Mediators of cancer progression and targets for cancer therapy
-
Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 2012; 33: 207-14.
-
(2012)
Trends Pharmacol Sci
, vol.33
, pp. 207-214
-
-
Semenza, G.L.1
-
117
-
-
84857048135
-
Modulation of hypoxia-inducible factors (HIF) from an integrative pharmacological perspective
-
Rodriguez-Jimenez FJ, Moreno-Manzano V. Modulation of hypoxia-inducible factors (HIF) from an integrative pharmacological perspective. Cell Mol Life Sci 2012; 69: 519-34.
-
(2012)
Cell Mol Life Sci
, vol.69
, pp. 519-534
-
-
Rodriguez-Jimenez, F.J.1
Moreno-Manzano, V.2
-
118
-
-
78650890352
-
Regulation of autophagy by ROS: Physiology and pathology
-
Scherz-Shouval R, Elazar Z. Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci 2011; 36: 30-8.
-
(2011)
Trends Biochem Sci
, vol.36
, pp. 30-38
-
-
Scherz-Shouval, R.1
Elazar, Z.2
-
119
-
-
70849093542
-
Reactive oxygen species-dependent signaling regulates cancer
-
Weinberg F, Chandel NS. Reactive oxygen species-dependent signaling regulates cancer. Cell Mol Life Sci 2009; 66: 3663-73.
-
(2009)
Cell Mol Life Sci
, vol.66
, pp. 3663-3673
-
-
Weinberg, F.1
Chandel, N.S.2
-
120
-
-
79955755461
-
Inborn and acquired metabolic defects in cancer
-
Frezza C, Pollard PJ, Gottlieb E. Inborn and acquired metabolic defects in cancer. J Mol Med 2011; 89: 213-20.
-
(2011)
J Mol Med
, vol.89
, pp. 213-220
-
-
Frezza, C.1
Pollard, P.J.2
Gottlieb, E.3
-
121
-
-
84863456251
-
The mechanisms of IDH mutations in tumorigenesis
-
Ye D, Xiong Y, Guan KL. The mechanisms of IDH mutations in tumorigenesis. Cell Res 2012; 22:1102-4.
-
(2012)
Cell Res
, vol.22
, pp. 1102-1104
-
-
Ye, D.1
Xiong, Y.2
Guan, K.L.3
-
122
-
-
83755178091
-
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability
-
Wise DR, Ward PS, Shay JE, et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci USA 2011; 108: 19611-6.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 19611-19616
-
-
Wise, D.R.1
Ward, P.S.2
Shay, J.E.3
-
123
-
-
84858796262
-
IDH mutation impairs histone demethylation and results in a block to cell differentiation
-
Lu C, Ward PS, Kapoor GS, et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 2012; 483:474-8.
-
(2012)
Nature
, vol.483
, pp. 474-478
-
-
Lu, C.1
Ward, P.S.2
Kapoor, G.S.3
-
124
-
-
1642430733
-
Myc pathways provoking cell suicide and cancer
-
Nilsson JA, Cleveland JL. Myc pathways provoking cell suicide and cancer. Oncogene 2003; 22: 9007-21.
-
(2003)
Oncogene
, vol.22
, pp. 9007-9021
-
-
Nilsson, J.A.1
Cleveland, J.L.2
-
125
-
-
70350728803
-
MYC-induced cancer cell energy metabolism and therapeutic opportunities
-
Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res 2009; 15: 6479-83.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 6479-6483
-
-
Dang, C.V.1
Le, A.2
Gao, P.3
-
127
-
-
34548257176
-
HIF-dependent antitumorigenic effect of antioxidants in vivo
-
Gao P, Zhang H, Dinavahi R, et al. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell 2007; 12: 230-8.
-
(2007)
Cancer Cell
, vol.12
, pp. 230-238
-
-
Gao, P.1
Zhang, H.2
Dinavahi, R.3
-
128
-
-
77951432631
-
The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation-why mitochondria are targets for cancer therapy
-
Ralph SJ, Rodriguez-Enriquez S, Neuzil J, Saavedra E, Moreno-Sanchez R. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation-why mitochondria are targets for cancer therapy. Mol Aspects Med 2010; 31: 145-70.
-
(2010)
Mol Aspects Med
, vol.31
, pp. 145-170
-
-
Ralph, S.J.1
Rodriguez-Enriquez, S.2
Neuzil, J.3
Saavedra, E.4
Moreno-Sanchez, R.5
-
129
-
-
33751101848
-
Anti-adipogenic activity of rutin in 3T3-L1 cells and mice fed with high-fat diet
-
Choi I, Park Y, Choi H, Lee EH. Anti-adipogenic activity of rutin in 3T3-L1 cells and mice fed with high-fat diet. Biofactors 2006; 26: 273-81.
-
(2006)
Biofactors
, vol.26
, pp. 273-281
-
-
Choi, I.1
Park, Y.2
Choi, H.3
Lee, E.H.4
-
131
-
-
76349095132
-
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
-
Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010; 29: 625-34.
-
(2010)
Oncogene
, vol.29
, pp. 625-634
-
-
Semenza, G.L.1
-
132
-
-
77949967131
-
Targeting metabolic transformation for cancer therapy
-
Tennant DA, Duran RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 2010; 10: 267-77.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 267-277
-
-
Tennant, D.A.1
Duran, R.V.2
Gottlieb, E.3
-
133
-
-
79955759406
-
Therapeutic targeting of cancer cell metabolism
-
Dang CV, Hamaker M, Sun P, Le A, Gao P. Therapeutic targeting of cancer cell metabolism. J Molec Med 2011; 89: 205-12.
-
(2011)
J Molec Med
, vol.89
, pp. 205-212
-
-
Dang, C.V.1
Hamaker, M.2
Sun, P.3
Le, A.4
Gao, P.5
-
134
-
-
80155167845
-
Mitochondria as therapeutic targets for the treatment of malignant disease
-
Fulda S, Kroemer G. Mitochondria as therapeutic targets for the treatment of malignant disease. Antioxid Redox Signal 2011; 15: 2937-49.
-
(2011)
Antioxid Redox Signal
, vol.15
, pp. 2937-2949
-
-
Fulda, S.1
Kroemer, G.2
-
135
-
-
84856227857
-
Mitochondrial metabolism inhibitors for cancer therapy
-
Ramsay EE, Hogg PJ, Dilda PJ. Mitochondrial metabolism inhibitors for cancer therapy. Pharm Res 2011; 28: 2731-44.
-
(2011)
Pharm Res
, vol.28
, pp. 2731-2744
-
-
Ramsay, E.E.1
Hogg, P.J.2
Dilda, P.J.3
-
136
-
-
79959621970
-
Predicting selective drug targets in cancer through metabolic networks
-
Folger O, Jerby L, Frezza C, Gottlieb E, Ruppin E, Shlomi T. Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol 2011; 7: 501.
-
(2011)
Mol Syst Biol
, vol.7
, pp. 501
-
-
Folger, O.1
Jerby, L.2
Frezza, C.3
Gottlieb, E.4
Ruppin, E.5
Shlomi, T.6
-
137
-
-
77951231349
-
mTOR and cancer: Many loops in one pathway
-
Efeyan A, Sabatini DM. mTOR and cancer: many loops in one pathway. Curr Opin Cell Biol 2010; 22: 169-76.
-
(2010)
Curr Opin Cell Biol
, vol.22
, pp. 169-176
-
-
Efeyan, A.1
Sabatini, D.M.2
-
138
-
-
32944457518
-
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
-
O'Reilly KE, Rojo F, She QB, et al. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 2006; 66: 1500-8.
-
(2006)
Cancer Res
, vol.66
, pp. 1500-1508
-
-
O'Reilly, K.E.1
Rojo, F.2
She, Q.B.3
-
139
-
-
51049109033
-
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
-
Maira SM, Stauffer F, Brueggen J, et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther 2008; 7: 1851-63.
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 1851-1863
-
-
Maira, S.M.1
Stauffer, F.2
Brueggen, J.3
-
140
-
-
84864371674
-
Metformin and cancer: New applications for an old drug
-
Kourelis TV, Siegel RD. Metformin and cancer: new applications for an old drug. Med Oncol 2012; 29: 1314-27.
-
(2012)
Med Oncol
, vol.29
, pp. 1314-1327
-
-
Kourelis, T.V.1
Siegel, R.D.2
-
141
-
-
80053992117
-
Metformin as an antitumor agent in cancer prevention and treatment
-
Li D. Metformin as an antitumor agent in cancer prevention and treatment. J Diabetes 2011; 3: 320-7.
-
(2011)
J Diabetes
, vol.3
, pp. 320-327
-
-
Li, D.1
-
143
-
-
84255178432
-
Diabetes, cancer, and metformin: Connections of metabolism and cell proliferation
-
Gallagher EJ, LeRoith D. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation. Ann NY Acad Sci 2011; 1243: 54-68.
-
(2011)
Ann NY Acad Sci
, vol.1243
, pp. 54-68
-
-
Gallagher, E.J.1
LeRoith, D.2
-
144
-
-
33744537111
-
Metformin and the fate of fat
-
Hoek JB. Metformin and the fate of fat. Gastroenterology 2006; 130: 2234-7.
-
(2006)
Gastroenterology
, vol.130
, pp. 2234-2237
-
-
Hoek, J.B.1
-
145
-
-
33748118458
-
Neither LKB1 nor AMPK are direct targets of metformin
-
Hardie DG. Neither LKB1 nor AMPK are direct targets of metformin. Gastroenterology 2006; 131: 973.
-
(2006)
Gastroenterology
, vol.131
, pp. 973
-
-
Hardie, D.G.1
-
147
-
-
0034614420
-
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
-
El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 2000; 275: 223-8.
-
(2000)
J Biol Chem
, vol.275
, pp. 223-228
-
-
El-Mir, M.Y.1
Nogueira, V.2
Fontaine, E.3
Averet, N.4
Rigoulet, M.5
Leverve, X.6
-
148
-
-
0034659785
-
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
-
Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 2000; 348 Pt 3: 607-14.
-
(2000)
Biochem J
, vol.348
, Issue.Pt 3
, pp. 607-614
-
-
Owen, M.R.1
Doran, E.2
Halestrap, A.P.3
-
149
-
-
84855603512
-
Cellular and molecular mechanisms of metformin: An overview
-
Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin Sci 2012; 122: 253-70.
-
(2012)
Clin Sci
, vol.122
, pp. 253-270
-
-
Viollet, B.1
Guigas, B.2
Sanz Garcia, N.3
Leclerc, J.4
Foretz, M.5
Andreelli, F.6
-
150
-
-
75349099919
-
Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer
-
Fogarty S, Hardie DG. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim Biophys Acta 2010; 1804: 581-91.
-
(2010)
Biochim Biophys Acta
, vol.1804
, pp. 581-591
-
-
Fogarty, S.1
Hardie, D.G.2
-
151
-
-
28244466264
-
5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase
-
Rattan R, Giri S, Singh AK, Singh I. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. J Biol Chem 2005; 280: 39582-93.
-
(2005)
J Biol Chem
, vol.280
, pp. 39582-39593
-
-
Rattan, R.1
Giri, S.2
Singh, A.K.3
Singh, I.4
-
152
-
-
34547114031
-
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
-
Buzzai M, Jones RG, Amaravadi RK, et al. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 2007; 67: 6745-52.
-
(2007)
Cancer Res
, vol.67
, pp. 6745-6752
-
-
Buzzai, M.1
Jones, R.G.2
Amaravadi, R.K.3
-
153
-
-
79955623949
-
AICAR inhibits cancer cell growth and triggers cell-type distinct effects on OXPHOS biogenesis, oxidative stress and Akt activation
-
Jose C, Hebert-Chatelain E, Bellance N, et al. AICAR inhibits cancer cell growth and triggers cell-type distinct effects on OXPHOS biogenesis, oxidative stress and Akt activation. Biochim Biophys Acta 2011; 1807: 707-18.
-
(2011)
Biochim Biophys Acta
, vol.1807
, pp. 707-718
-
-
Jose, C.1
Hebert-Chatelain, E.2
Bellance, N.3
-
154
-
-
79959998541
-
LKB1/AMPK/mTOR signaling pathway in hematological malignancies: From metabolism to cancer cell biology
-
Green AS, Chapuis N, Lacombe C, Mayeux P, Bouscary D, Tamburini J. LKB1/AMPK/mTOR signaling pathway in hematological malignancies: from metabolism to cancer cell biology. Cell Cycle 2011; 10: 2115-20.
-
(2011)
Cell Cycle
, vol.10
, pp. 2115-2120
-
-
Green, A.S.1
Chapuis, N.2
Lacombe, C.3
Mayeux, P.4
Bouscary, D.5
Tamburini, J.6
-
155
-
-
0345107247
-
Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade
-
Hawley SA, Boudeau J, Reid JL, et al. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2003; 2: 28.
-
(2003)
J Biol
, vol.2
, pp. 28
-
-
Hawley, S.A.1
Boudeau, J.2
Reid, J.L.3
-
156
-
-
10744230065
-
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
-
Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M, Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 2003; 13: 2004-8.
-
(2003)
Curr Biol
, vol.13
, pp. 2004-2008
-
-
Woods, A.1
Johnstone, S.R.2
Dickerson, K.3
Leiper, F.C.4
Fryer, L.G.5
Neumann, D.6
Schlattner, U.7
Wallimann, T.8
Carlson, M.9
Carling, D.10
-
157
-
-
77954335451
-
Regulation of skeletal muscle mitochondrial function: Genes to proteins
-
Lanza IR, Sreekumaran Nair K. Regulation of skeletal muscle mitochondrial function: genes to proteins. Acta Physiol 2010; 199: 529-47.
-
(2010)
Acta Physiol
, vol.199
, pp. 529-547
-
-
Lanza, I.R.1
Sreekumaran Nair, K.2
-
159
-
-
77955571892
-
Regular exercise reduces colon tumorigenesis associated with suppression of iNOS
-
Aoi W, Naito Y, Takagi T, et al. Regular exercise reduces colon tumorigenesis associated with suppression of iNOS. Biochem Biophys Res Commun 2010; 399: 14-9.
-
(2010)
Biochem Biophys Res Commun
, vol.399
, pp. 14-19
-
-
Aoi, W.1
Naito, Y.2
Takagi, T.3
-
160
-
-
69449090229
-
Physical activity reduces prostate carcinogenesis in a transgenic model
-
Esser KA, Harpole CE, Prins GS, Diamond AM. Physical activity reduces prostate carcinogenesis in a transgenic model. Prostate 2009; 69: 1372-7.
-
(2009)
Prostate
, vol.69
, pp. 1372-1377
-
-
Esser, K.A.1
Harpole, C.E.2
Prins, G.S.3
Diamond, A.M.4
-
161
-
-
0043240126
-
Moderate exercise training slows mammary tumor growth in adolescent rats
-
Westerlind KC, McCarty HL, Schultheiss PC, et al. Moderate exercise training slows mammary tumor growth in adolescent rats. Eur J Cancer Prev 2003; 12: 281-7.
-
(2003)
Eur J Cancer Prev
, vol.12
, pp. 281-287
-
-
Westerlind, K.C.1
McCarty, H.L.2
Schultheiss, P.C.3
-
162
-
-
75749127856
-
Effect of aerobic exercise on tumor physiology in an animal model of human breast cancer
-
Jones LW, Viglianti BL, Tashjian JA, et al. Effect of aerobic exercise on tumor physiology in an animal model of human breast cancer. J Appl Physiol 2010; 108: 343-8.
-
(2010)
J Appl Physiol
, vol.108
, pp. 343-348
-
-
Jones, L.W.1
Viglianti, B.L.2
Tashjian, J.A.3
-
164
-
-
80555147884
-
Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells
-
Luo W, Semenza GL. Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells. Oncotarget 2011; 2: 551-6.
-
(2011)
Oncotarget
, vol.2
, pp. 551-556
-
-
Luo, W.1
Semenza, G.L.2
-
165
-
-
46649106720
-
Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels
-
Chiara F, Castellaro D, Marin O, et al. Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels. Plos One 2008; 3: e1852.
-
(2008)
Plos One
, vol.3
-
-
Chiara, F.1
Castellaro, D.2
Marin, O.3
-
166
-
-
47749093652
-
Methyl jasmonate binds to and detaches mitochondria-bound hexokinase
-
Goldin N, Arzoine L, Heyfets A, et al. Methyl jasmonate binds to and detaches mitochondria-bound hexokinase. Oncogene 2008; 27: 4636-43.
-
(2008)
Oncogene
, vol.27
, pp. 4636-4643
-
-
Goldin, N.1
Arzoine, L.2
Heyfets, A.3
-
167
-
-
4744341871
-
Advanced cancers: Eradication in all cases using 3-bromopyruvate therapy to deplete ATP
-
Ko YH, Smith BL, Wang Y, et al. Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun 2004; 324: 269-75.
-
(2004)
Biochem Biophys Res Commun
, vol.324
, pp. 269-275
-
-
Ko, Y.H.1
Smith, B.L.2
Wang, Y.3
-
168
-
-
65449119234
-
Role of mitochondriaassociated hexokinase II in cancer cell death induced by 3-bromopyruvate
-
Chen Z, Zhang H, Lu W, Huang P. Role of mitochondriaassociated hexokinase II in cancer cell death induced by 3-bromopyruvate. Biochim Biophys Acta 2009; 1787: 553-60.
-
(2009)
Biochim Biophys Acta
, vol.1787
, pp. 553-560
-
-
Chen, Z.1
Zhang, H.2
Lu, W.3
Huang, P.4
-
169
-
-
84858704865
-
3-Bromopyruvate: Targets and outcomes
-
Shoshan MC. 3-Bromopyruvate: targets and outcomes. J Bioenerg Biomembr 2012; 44: 7-15.
-
(2012)
J Bioenerg Biomembr
, vol.44
, pp. 7-15
-
-
Shoshan, M.C.1
-
170
-
-
84862809596
-
A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: From bench side to bedside
-
Ko YH, Verhoeven HA, Lee MJ, Corbin DJ, Vogl TJ, Pedersen PL. A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside. J Bioenerg Biomembr 2012; 44: 163-70.
-
(2012)
J Bioenerg Biomembr
, vol.44
, pp. 163-170
-
-
Ko, Y.H.1
Verhoeven, H.A.2
Lee, M.J.3
Corbin, D.J.4
Vogl, T.J.5
Pedersen, P.L.6
-
171
-
-
0024208697
-
Nutritional pharmacology in the treatment of neoplastic disease
-
Fearon KC. Nutritional pharmacology in the treatment of neoplastic disease. Baillieres Clin Gastroenterol 1988; 2: 941-9.
-
(1988)
Baillieres Clin Gastroenterol
, vol.2
, pp. 941-949
-
-
Fearon, K.C.1
-
172
-
-
84864108226
-
The ketogenic diet for the treatment of glioma: Insights from genetic profiling
-
Scheck AC, Abdelwahab MG, Fenton KE, Stafford P. The ketogenic diet for the treatment of glioma: Insights from genetic profiling. Epilepsy Res 2012; 100: 327-72.
-
(2012)
Epilepsy Res
, vol.100
, pp. 327-372
-
-
Scheck, A.C.1
Abdelwahab, M.G.2
Fenton, K.E.3
Stafford, P.4
-
173
-
-
84856364753
-
Is there a role for carbohydrate restriction in the treatment and prevention of cancer?
-
Klement RJ, Kammerer U. Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab 2011; 8: 75.
-
(2011)
Nutr Metab
, vol.8
, pp. 75
-
-
Klement, R.J.1
Kammerer, U.2
-
174
-
-
77951233713
-
Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet
-
Seyfried BT, Kiebish M, Marsh J, Mukherjee P. Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet. J Cancer Res Ther 2009; 5: S7-15.
-
(2009)
J Cancer Res Ther
, vol.5
-
-
Seyfried, B.T.1
Kiebish, M.2
Marsh, J.3
Mukherjee, P.4
-
175
-
-
79955598077
-
Metabolic management of brain cancer
-
Seyfried TN, Kiebish MA, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P. Metabolic management of brain cancer. Biochim Biophys Acta 2011; 1807: 577-94.
-
(2011)
Biochim Biophys Acta
, vol.1807
, pp. 577-594
-
-
Seyfried, T.N.1
Kiebish, M.A.2
Marsh, J.3
Shelton, L.M.4
Huysentruyt, L.C.5
Mukherjee, P.6
-
176
-
-
58149161852
-
Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet
-
Marsh J, Mukherjee P, Seyfried TN. Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet. Nutr Metab, 2008; 5: 33.
-
(2008)
Nutr Metab
, vol.5
, pp. 33
-
-
Marsh, J.1
Mukherjee, P.2
Seyfried, T.N.3
-
177
-
-
84871706742
-
Carbohydrate restriction and lactate transporter inhibition in a mouse xenograft model of human prostate cancer
-
Kim HS, Masko EM, Poulton SL, et al. Carbohydrate restriction and lactate transporter inhibition in a mouse xenograft model of human prostate cancer. BJU Int 2012; 110: 1062-9.
-
(2012)
BJU Int
, vol.110
, pp. 1062-1069
-
-
Kim, H.S.1
Masko, E.M.2
Poulton, S.L.3
-
178
-
-
33846002728
-
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
-
Bonnet S, Archer SL, Allalunis-Turner J, et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007; 11: 37-51.
-
(2007)
Cancer Cell
, vol.11
, pp. 37-51
-
-
Bonnet, S.1
Archer, S.L.2
Allalunis-Turner, J.3
-
179
-
-
74849137483
-
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo
-
Sun RC, Fadia M, Dahlstrom JE, Parish CR, Board PG, Blackburn AC. Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo. Breast Cancer Res Treat 2010; 120: 253-60.
-
(2010)
Breast Cancer Res Treat
, vol.120
, pp. 253-260
-
-
Sun, R.C.1
Fadia, M.2
Dahlstrom, J.E.3
Parish, C.R.4
Board, P.G.5
Blackburn, A.C.6
-
180
-
-
78650722178
-
Anticancer drugs that target metabolism: Is dichloroacetate the new paradigm?
-
Papandreou I, Goliasova T, Denko NC. Anticancer drugs that target metabolism: Is dichloroacetate the new paradigm? Int J Cancer 2011; 128: 1001-8.
-
(2011)
Int J Cancer
, vol.128
, pp. 1001-1008
-
-
Papandreou, I.1
Goliasova, T.2
Denko, N.C.3
-
182
-
-
81255178599
-
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
-
Sun RC, Board PG, Blackburn AC. Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells. Mol Cancer 2011; 10: 142.
-
(2011)
Mol Cancer
, vol.10
, pp. 142
-
-
Sun, R.C.1
Board, P.G.2
Blackburn, A.C.3
-
183
-
-
33744783432
-
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
-
Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006; 9: 425-34.
-
(2006)
Cancer Cell
, vol.9
, pp. 425-434
-
-
Fantin, V.R.1
St-Pierre, J.2
Leder, P.3
-
184
-
-
57449097020
-
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
-
Sonveaux P, Vegran F, Schroeder T, et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008; 118: 3930-42.
-
(2008)
J Clin Invest
, vol.118
, pp. 3930-3942
-
-
Sonveaux, P.1
Vegran, F.2
Schroeder, T.3
-
185
-
-
57449115616
-
Tumor metabolism: Cancer cells give and take lactate
-
Semenza GL. Tumor metabolism: cancer cells give and take lactate. J Clin Invest 2008; 118: 3835-7.
-
(2008)
J Clin Invest
, vol.118
, pp. 3835-3837
-
-
Semenza, G.L.1
-
186
-
-
84857716739
-
Multiple biological activities of lactic acid in cancer: Influences on tumor growth, angiogenesis and metastasis
-
Dhup S, Dadhich RK, Porporato PE, Sonveaux P. Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis. Curr Pharm Des 2012; 18: 1319-30.
-
(2012)
Curr Pharm Des
, vol.18
, pp. 1319-1330
-
-
Dhup, S.1
Dadhich, R.K.2
Porporato, P.E.3
Sonveaux, P.4
-
187
-
-
84858120137
-
Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis
-
Sonveaux P, Copetti T, De Saedeleer CJ, et al. Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis. Plos One 2012; 7: e33418.
-
(2012)
Plos One
, vol.7
-
-
Sonveaux, P.1
Copetti, T.2
De Saedeleer, C.J.3
-
188
-
-
0027180685
-
Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate
-
Samid D, Shack S, Myers CE. Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate. J Clin Invest 1993; 91: 2288-95.
-
(1993)
J Clin Invest
, vol.91
, pp. 2288-2295
-
-
Samid, D.1
Shack, S.2
Myers, C.E.3
-
190
-
-
0036841299
-
Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells
-
Bode BP, Fuchs BC, Hurley BP, et al. Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1062-73.
-
(2002)
Am J Physiol Gastrointest Liver Physiol
, vol.283
-
-
Bode, B.P.1
Fuchs, B.C.2
Hurley, B.P.3
-
191
-
-
23044474905
-
Amino acid transporters ASCT2 and LAT1 in cancer: Partners in crime?
-
Fuchs BC, Bode BP. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol 2005; 15: 254-66.
-
(2005)
Semin Cancer Biol
, vol.15
, pp. 254-266
-
-
Fuchs, B.C.1
Bode, B.P.2
-
192
-
-
1342322886
-
Inducible antisense RNA targeting amino acid transporter ATB0/ASCT2 elicits apoptosis in human hepatoma cells
-
Fuchs BC, Perez JC, Suetterlin JE, Chaudhry SB, Bode BP. Inducible antisense RNA targeting amino acid transporter ATB0/ASCT2 elicits apoptosis in human hepatoma cells. Am J Physiol Gastrointest Liver Physiol 2004; 286: G467-78.
-
(2004)
Am J Physiol Gastrointest Liver Physiol
, vol.286
-
-
Fuchs, B.C.1
Perez, J.C.2
Suetterlin, J.E.3
Chaudhry, S.B.4
Bode, B.P.5
-
193
-
-
34249803325
-
The transport of glutamine into mammalian cells
-
McGivan JD, Bungard CI. The transport of glutamine into mammalian cells. Front Biosci 2007; 12: 874-82.
-
(2007)
Front Biosci
, vol.12
, pp. 874-882
-
-
McGivan, J.D.1
Bungard, C.I.2
-
194
-
-
57749111596
-
Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond
-
Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 2009; 121: 29-40.
-
(2009)
Pharmacol Ther
, vol.121
, pp. 29-40
-
-
Ganapathy, V.1
Thangaraju, M.2
Prasad, P.D.3
-
195
-
-
79956041076
-
The role of amino acid transporters in inherited and acquired diseases
-
Broer S, Palacin M. The role of amino acid transporters in inherited and acquired diseases. Biochem J 2011; 436: 193-211.
-
(2011)
Biochem J
, vol.436
, pp. 193-211
-
-
Broer, S.1
Palacin, M.2
-
196
-
-
33646540633
-
L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors
-
Nawashiro H, Otani N, Shinomiya N, et al. L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. Int J Cancer 2006; 119: 484-92.
-
(2006)
Int J Cancer
, vol.119
, pp. 484-492
-
-
Nawashiro, H.1
Otani, N.2
Shinomiya, N.3
-
198
-
-
0015748593
-
Asparagine-requiring tumor cell lines and their non-requiring variants: Cytogenetics, biochemistry and population dynamics
-
Colofiore J, Morrow J, Patterson MK, Jr. Asparagine-requiring tumor cell lines and their non-requiring variants: cytogenetics, biochemistry and population dynamics. Genetics 1973; 75: 503-14.
-
(1973)
Genetics
, vol.75
, pp. 503-514
-
-
Colofiore, J.1
Morrow, J.2
Patterson Jr., M.K.3
-
199
-
-
77951903067
-
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
-
Delage B, Fennell DA, Nicholson L, et al. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int J Cancer, 2010; 126: 2762-72.
-
(2010)
Int J Cancer
, vol.126
, pp. 2762-2772
-
-
Delage, B.1
Fennell, D.A.2
Nicholson, L.3
-
200
-
-
33750310241
-
Genetic disorders of adipose tissue development, differentiation, and death
-
Agarwal AK, Garg A. Genetic disorders of adipose tissue development, differentiation, and death. Annu Rev Genom Hum Genet 2006; 7: 175-99.
-
(2006)
Annu Rev Genom Hum Genet
, vol.7
, pp. 175-199
-
-
Agarwal, A.K.1
Garg, A.2
-
201
-
-
84859400805
-
Nutritional stress and arginine auxotrophy confer high sensitivity to chloroquine toxicity in mesothelioma cells
-
Battisti S, Valente D, Albonici L, Bei R, Modesti A, Palumbo C. Nutritional stress and arginine auxotrophy confer high sensitivity to chloroquine toxicity in mesothelioma cells. Am J Respir Cell Mol Biol 2012; 46: 498-506.
-
(2012)
Am J Respir Cell Mol Biol
, vol.46
, pp. 498-506
-
-
Battisti, S.1
Valente, D.2
Albonici, L.3
Bei, R.4
Modesti, A.5
Palumbo, C.6
-
202
-
-
78651059309
-
Metabolism of neoplastic tissue. I. The oxidation of carbohydrate and fatty acids in transplanted tumors
-
Weinhouse S, Millington RH, Wenner CE. Metabolism of neoplastic tissue. I. The oxidation of carbohydrate and fatty acids in transplanted tumors. Cancer Res 1951; 11: 845-50.
-
(1951)
Cancer Res
, vol.11
, pp. 845-850
-
-
Weinhouse, S.1
Millington, R.H.2
Wenner, C.E.3
-
203
-
-
58149308842
-
Fatty acid synthase activity in tumor cells
-
Little JL, Kridel SJ. Fatty acid synthase activity in tumor cells. Subcell Biochem 2008; 49: 169-94.
-
(2008)
Subcell Biochem
, vol.49
, pp. 169-194
-
-
Little, J.L.1
Kridel, S.J.2
-
204
-
-
19944374798
-
Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells
-
Wang HQ, Altomare DA, Skele KL, et al. Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells. Oncogene 2005; 24: 3574-82.
-
(2005)
Oncogene
, vol.24
, pp. 3574-3582
-
-
Wang, H.Q.1
Altomare, D.A.2
Skele, K.L.3
-
205
-
-
57349175482
-
Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model
-
Carvalho MA, Zecchin KG, Seguin F, et al. Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model. Int J Cancer 2008; 123: 2557-65.
-
(2008)
Int J Cancer
, vol.123
, pp. 2557-2565
-
-
Carvalho, M.A.1
Zecchin, K.G.2
Seguin, F.3
-
206
-
-
67349217677
-
Inhibition of fatty acid synthase by Orlistat accelerates gastric tumor cell apoptosis in culture and increases survival rates in gastric tumor bearing mice in vivo
-
Dowling S, Cox J, Cenedella RJ. Inhibition of fatty acid synthase by Orlistat accelerates gastric tumor cell apoptosis in culture and increases survival rates in gastric tumor bearing mice in vivo. Lipids 2009; 44: 489-98.
-
(2009)
Lipids
, vol.44
, pp. 489-498
-
-
Dowling, S.1
Cox, J.2
Cenedella, R.J.3
-
207
-
-
57649128306
-
Inhibition of fattyacid synthase induces caspase-8-mediated tumor cell apoptosis by up-regulating DDIT4
-
Knowles LM, Yang C, Osterman A, Smith JW. Inhibition of fattyacid synthase induces caspase-8-mediated tumor cell apoptosis by up-regulating DDIT4. J Biol Chem 2008; 283: 31378-84.
-
(2008)
J Biol Chem
, vol.283
, pp. 31378-31384
-
-
Knowles, L.M.1
Yang, C.2
Osterman, A.3
Smith, J.W.4
-
208
-
-
53849087867
-
Synthesis of novel betalactone inhibitors of fatty acid synthase
-
Richardson RD, Ma G, Oyola Y, et al. Synthesis of novel betalactone inhibitors of fatty acid synthase. J Med Chem 2008; 51: 5285-96.
-
(2008)
J Med Chem
, vol.51
, pp. 5285-5296
-
-
Richardson, R.D.1
Ma, G.2
Oyola, Y.3
-
209
-
-
74949089659
-
Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction
-
Samudio I, Harmancey R, Fiegl M, et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest 2010; 120: 142-56.
-
(2010)
J Clin Invest
, vol.120
, pp. 142-156
-
-
Samudio, I.1
Harmancey, R.2
Fiegl, M.3
-
210
-
-
77649183649
-
Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger
-
Ralph SJ, Rodriguez-Enriquez S, Neuzil J, Moreno-Sanchez R. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. Mol Aspect Med 2010; 31: 29-59.
-
(2010)
Mol Aspect Med
, vol.31
, pp. 29-59
-
-
Ralph, S.J.1
Rodriguez-Enriquez, S.2
Neuzil, J.3
Moreno-Sanchez, R.4
-
211
-
-
33745728461
-
Fatty acid synthase and cancer: New application of an old pathway
-
Kuhajda FP. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res 2006; 66: 5977-80.
-
(2006)
Cancer Res
, vol.66
, pp. 5977-5980
-
-
Kuhajda, F.P.1
-
212
-
-
37249017959
-
Selective inhibition of fatty acid synthase for lung cancer treatment
-
Orita H, Coulter J, Lemmon C, et al. Selective inhibition of fatty acid synthase for lung cancer treatment. Clin Cancer Res 2007; 13: 7139-45.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 7139-7145
-
-
Orita, H.1
Coulter, J.2
Lemmon, C.3
-
213
-
-
34547481318
-
An NQO1-and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone
-
Bey EA, Bentle MS, Reinicke KE, et al. An NQO1-and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone. Proc Natl Acad Sci USA 2007; 104: 11832-7.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 11832-11837
-
-
Bey, E.A.1
Bentle, M.S.2
Reinicke, K.E.3
-
214
-
-
0034009970
-
NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity
-
Pink JJ, Planchon SM, Tagliarino C, Varnes ME, Siegel D, Boothman DA. NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity. J Biol Chem 2000; 275: 5416-24.
-
(2000)
J Biol Chem
, vol.275
, pp. 5416-5424
-
-
Pink, J.J.1
Planchon, S.M.2
Tagliarino, C.3
Varnes, M.E.4
Siegel, D.5
Boothman, D.A.6
-
215
-
-
33748146888
-
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate
-
Trachootham D, Zhou Y, Zhang H, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 2006; 10: 241-52.
-
(2006)
Cancer Cell
, vol.10
, pp. 241-252
-
-
Trachootham, D.1
Zhou, Y.2
Zhang, H.3
-
216
-
-
33750448018
-
Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential
-
Xiao D, Lew KL, Zeng Y, et al. Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential. Carcinogenesis 2006; 27: 2223-34.
-
(2006)
Carcinogenesis
, vol.27
, pp. 2223-2234
-
-
Xiao, D.1
Lew, K.L.2
Zeng, Y.3
-
217
-
-
77957958015
-
Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound beta-phenylethyl isothiocyanate
-
Hu Y, Lu W, Chen G, et al. Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound beta-phenylethyl isothiocyanate. Blood 2010; 116: 2732-41.
-
(2010)
Blood
, vol.116
, pp. 2732-2741
-
-
Hu, Y.1
Lu, W.2
Chen, G.3
-
218
-
-
0027164144
-
High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
-
Campos L, Rouault JP, Sabido O, et al. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993; 81: 3091-6.
-
(1993)
Blood
, vol.81
, pp. 3091-3096
-
-
Campos, L.1
Rouault, J.P.2
Sabido, O.3
-
219
-
-
0028322065
-
Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma
-
Dole M, Nunez G, Merchant AK, et al. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 1994; 54: 3253-9.
-
(1994)
Cancer Res
, vol.54
, pp. 3253-3259
-
-
Dole, M.1
Nunez, G.2
Merchant, A.K.3
-
220
-
-
20444486559
-
An inhibitor of Bcl-2 family proteins induces regression of solid tumors
-
Oltersdorf T, Elmore SW, Shoemaker AR, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumors. Nature 2005; 435: 677-81.
-
(2005)
Nature
, vol.435
, pp. 677-681
-
-
Oltersdorf, T.1
Elmore, S.W.2
Shoemaker, A.R.3
-
221
-
-
58149168589
-
Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy
-
Azmi AS, Mohammad RM. Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy. J Cell Physiol 2009; 218: 13-21.
-
(2009)
J Cell Physiol
, vol.218
, pp. 13-21
-
-
Azmi, A.S.1
Mohammad, R.M.2
-
222
-
-
0027460576
-
Oral gossypol in the treatment of metastatic adrenal cancer
-
Flack MR, Pyle RG, Mullen NM, et al. Oral gossypol in the treatment of metastatic adrenal cancer. J Clin Endocrinol Metab 1993; 76: 1019-24.
-
(1993)
J Clin Endocrinol Metab
, vol.76
, pp. 1019-1024
-
-
Flack, M.R.1
Pyle, R.G.2
Mullen, N.M.3
-
223
-
-
0026687876
-
A preliminary clinical study of gossypol in advanced human cancer
-
Stein RC, Joseph AE, Matlin SA, Cunningham DC, Ford HT, Coombes RC. A preliminary clinical study of gossypol in advanced human cancer. Cancer Chemother Pharmacol 1992; 30: 480-2.
-
(1992)
Cancer Chemother Pharmacol
, vol.30
, pp. 480-482
-
-
Stein, R.C.1
Joseph, A.E.2
Matlin, S.A.3
Cunningham, D.C.4
Ford, H.T.5
Coombes, R.C.6
-
224
-
-
80052995730
-
A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensivestage small cell lung cancer
-
Baggstrom MQ, Qi Y, Koczywas M, et al. A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensivestage small cell lung cancer. J Thorac Oncol 2011; 6: 1757-60.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 1757-1760
-
-
Baggstrom, M.Q.1
Qi, Y.2
Koczywas, M.3
-
226
-
-
12844272321
-
Polyphenols and disease risk in epidemiologic studies
-
Arts IC, Hollman PC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005; 81: 317S-325S.
-
(2005)
Am J Clin Nutr
, vol.81
-
-
Arts, I.C.1
Hollman, P.C.2
-
227
-
-
0027291905
-
Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands
-
Hertog MG, Hollman PC, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 1993; 20: 21-9.
-
(1993)
Nutr Cancer
, vol.20
, pp. 21-29
-
-
Hertog, M.G.1
Hollman, P.C.2
Katan, M.B.3
Kromhout, D.4
-
228
-
-
33845505240
-
Chronic quercetin exposure affects fatty acid catabolism in rat lung
-
de Boer VC, van Schothorst EM, Dihal AA, et al. Chronic quercetin exposure affects fatty acid catabolism in rat lung. Cell Mol Life Sci 2006; 63: 2847-58.
-
(2006)
Cell Mol Life Sci
, vol.63
, pp. 2847-2858
-
-
de Boer, V.C.1
van Schothorst, E.M.2
Dihal, A.A.3
-
229
-
-
34548812546
-
A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties
-
Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM, Lines TC. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 2007; 45: 2179-205.
-
(2007)
Food Chem Toxicol
, vol.45
, pp. 2179-2205
-
-
Harwood, M.1
Danielewska-Nikiel, B.2
Borzelleca, J.F.3
Flamm, G.W.4
Williams, G.M.5
Lines, T.C.6
-
230
-
-
38149024191
-
Transcriptome and proteome profiling of colon mucosa from quercetin fed F344 rats point to tumor preventive mechanisms, increased mitochondrial fatty acid degradation and decreased glycolysis
-
Dihal AA, van der Woude H, Hendriksen PJ, et al. Transcriptome and proteome profiling of colon mucosa from quercetin fed F344 rats point to tumor preventive mechanisms, increased mitochondrial fatty acid degradation and decreased glycolysis. Proteomics 2008; 8: 45-61.
-
(2008)
Proteomics
, vol.8
, pp. 45-61
-
-
Dihal, A.A.1
van der Woude, H.2
Hendriksen, P.J.3
-
231
-
-
33646538121
-
SIRT1 stimulation by polyphenols is affected by their stability and metabolism
-
de Boer VC, de Goffau MC, Arts IC, Hollman PC, Keijer J. SIRT1 stimulation by polyphenols is affected by their stability and metabolism. Mech Ageing Dev 2006; 127: 618-27.
-
(2006)
Mech Ageing Dev
, vol.127
, pp. 618-627
-
-
de Boer, V.C.1
de Goffau, M.C.2
Arts, I.C.3
Hollman, P.C.4
Keijer, J.5
-
232
-
-
0026651085
-
Wine, alcohol, platelets, and the French paradox for coronary heart disease
-
Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-6.
-
(1992)
Lancet
, vol.339
, pp. 1523-1526
-
-
Renaud, S.1
de Lorgeril, M.2
-
233
-
-
33751072349
-
Resveratrol improves health and survival of mice on a high-calorie diet
-
Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444: 337-42.
-
(2006)
Nature
, vol.444
, pp. 337-342
-
-
Baur, J.A.1
Pearson, K.J.2
Price, N.L.3
-
234
-
-
33845399894
-
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha
-
Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006; 127: 1109-22.
-
(2006)
Cell
, vol.127
, pp. 1109-1122
-
-
Lagouge, M.1
Argmann, C.2
Gerhart-Hines, Z.3
-
235
-
-
57749170979
-
Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways
-
Roy P, Kalra N, Prasad S, George J, Shukla Y. Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways. Pharm res 2009; 26: 211-7.
-
(2009)
Pharm res
, vol.26
, pp. 211-217
-
-
Roy, P.1
Kalra, N.2
Prasad, S.3
George, J.4
Shukla, Y.5
-
236
-
-
48349110303
-
A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice
-
Barger JL, Kayo T, Vann JM, et al. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. Plos one, 2008; 3: e2264.
-
(2008)
Plos one
, vol.3
-
-
Barger, J.L.1
Kayo, T.2
Vann, J.M.3
-
237
-
-
48349144852
-
Resveratrol delays agerelated deterioration and mimics transcriptional aspects of dietary restriction without extending life span
-
Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol delays agerelated deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell metab 2008; 8: 157-68.
-
(2008)
Cell metab
, vol.8
, pp. 157-168
-
-
Pearson, K.J.1
Baur, J.A.2
Lewis, K.N.3
-
238
-
-
84863011114
-
Resveratrol ameliorates agingrelated metabolic phenotypes by inhibiting cAMP phosphodiesterases
-
Park SJ, Ahmad F, Philp A, et al. Resveratrol ameliorates agingrelated metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012; 148: 421-33.
-
(2012)
Cell
, vol.148
, pp. 421-433
-
-
Park, S.J.1
Ahmad, F.2
Philp, A.3
-
239
-
-
85027938576
-
SIRT1, metabolism and cancer
-
Knight JR, Milner J. SIRT1, metabolism and cancer. Curr opin oncol, 2012; 24: 68-75.
-
(2012)
Curr opin oncol
, vol.24
, pp. 68-75
-
-
Knight, J.R.1
Milner, J.2
-
240
-
-
77950348878
-
AMP-activated protein kinasedeficient mice are resistant to the metabolic effects of resveratrol
-
Um JH, Park SJ, Kang H, et al. AMP-activated protein kinasedeficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010; 59: 554-63.
-
(2010)
Diabetes
, vol.59
, pp. 554-563
-
-
Um, J.H.1
Park, S.J.2
Kang, H.3
-
241
-
-
79960081833
-
Resveratrol inhibits mTOR signaling by targeting DEPTOR
-
Liu M, Liu F. Resveratrol inhibits mTOR signaling by targeting DEPTOR. Commun integr biol 2011; 4: 382-4.
-
(2011)
Commun integr biol
, vol.4
, pp. 382-384
-
-
Liu, M.1
Liu, F.2
-
242
-
-
74849124984
-
Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy
-
Armour SM, Baur JA, Hsieh SN, Land-Bracha A, Thomas SM, Sinclair DA. Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy. Aging 2009; 1: 515-28.
-
(2009)
Aging
, vol.1
, pp. 515-528
-
-
Armour, S.M.1
Baur, J.A.2
Hsieh, S.N.3
Land-Bracha, A.4
Thomas, S.M.5
Sinclair, D.A.6
-
243
-
-
77954124151
-
The 4th Int Conf Polyphenol Health
-
Hollman PCH. The 4th Int Conf Polyphenol Health Nutr Bull 2010; 25: 183-5.
-
(2010)
Nutr Bull
, vol.25
, pp. 183-185
-
-
Hollman, P.C.H.1
-
244
-
-
79955506452
-
The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established
-
Hollman PC, Cassidy A, Comte B, et al. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J Nutr 2011; 141: 989S-1009S.
-
(2011)
J Nutr
, vol.141
-
-
Hollman, P.C.1
Cassidy, A.2
Comte, B.3
-
245
-
-
80155199811
-
Bcl-2: A prime regulator of mitochondrial redox metabolism in cancer cells
-
Low IC, Kang J, Pervaiz S. Bcl-2: a prime regulator of mitochondrial redox metabolism in cancer cells. Antioxid Redox Signal 2011; 15: 2975-87.
-
(2011)
Antioxid Redox Signal
, vol.15
, pp. 2975-2987
-
-
Low, I.C.1
Kang, J.2
Pervaiz, S.3
|